| Trial ID: | L3561 |
| Source ID: | NCT03248401
|
| Associated Drug: |
Cilostazol
|
| Title: |
Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Carotid Atherosclerosis
|
| Interventions: |
DRUG: Cilostazol|DRUG: Aspirin
|
| Outcome Measures: |
Primary: Change of carotid artery atherosclerosis, Plaque composition, 6 months | Secondary: Change of carotid artery atherosclerosis 1, Changes in carotid intima-media thickness after treatment, 6 months|Change of carotid artery atherosclerosis 2, Changes in carotid artery stenosis after treatment, 6 months|Change of carotid artery atherosclerosis 3, Plaque volume in carotid artery, 6 months | Other: Glucose metabolism 1, HOMA-Insulin Resistance, 6 months|Diabetic complication, Albuminuria, 6 months|Glucose metabolism 2, HbA1c, 6 months|Body composition, Body fat mass and percent, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Seoul National University Bundang Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2016-09-26
|
| Completion Date: |
2019-12-31
|
| Results First Posted: |
|
| Last Update Posted: |
2020-04-08
|
| Locations: |
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, 463-707, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT03248401
|
